| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of near fatal pulmonary embolism in a woman with lung cancer
|
Tsaroucha, E.
|
|
2018
|
164 |
S1 |
p. S221
|
artikel
|
| 2 |
Adverse events of rivaroxaban usage in cancer patients
|
Escalante, C.P.
|
|
2018
|
164 |
S1 |
p. S220-S221
|
artikel
|
| 3 |
A novel flow cytometry assay using dihydroethidium as redox-sensitive probe reveals NADPH oxidase-dependent generation of superoxide anion in human platelets
|
Abubaker, A.A.
|
|
2018
|
164 |
S1 |
p. S229-S230
|
artikel
|
| 4 |
Anti-angiogenesis for cancer: Current status and prospects
|
Russo, Massimo
|
|
2018
|
164 |
S1 |
p. S3-S6
|
artikel
|
| 5 |
Anticoagulation in Thrombocytopenic Patients with Hematological Malignancy: A Multi-center, Multinational Decision Making Analysis
|
Leader, A.
|
|
2018
|
164 |
S1 |
p. S185
|
artikel
|
| 6 |
Anticoagulation Therapy in SELECTeD Cancer Patients at Risk of Recurrence of Venous Thromboembolism: Results of the ‘select-d’ Pilot Trial
|
Young, A.
|
|
2018
|
164 |
S1 |
p. S194
|
artikel
|
| 7 |
Antidotes for the direct oral anticoagulants: What news?
|
Galliazzo, S.
|
|
2018
|
164 |
S1 |
p. S119-S123
|
artikel
|
| 8 |
Anti-platelet treatments in cancer: Basic and clinical research
|
Gresele, Paolo
|
|
2018
|
164 |
S1 |
p. S106-S111
|
artikel
|
| 9 |
Apixaban for the prevention of venous thromboembolism in high-risk ambulatory cancer patients receiving chemotherapy: Rational and design of the AVERT trial
|
Kimpton, Miriam
|
|
2018
|
164 |
S1 |
p. S124-S129
|
artikel
|
| 10 |
Application of an antithrombotic prophylaxis protocol in patients with multiple myeloma treated with Lenalidomide-Dexamethasone in our center. Thrombosis incidence
|
Revelles Peñas, M.
|
|
2018
|
164 |
S1 |
p. S236
|
artikel
|
| 11 |
Are new anticoagulants a safe and reasonable alternative to low molecular heparins?
|
Noble, Simon
|
|
2018
|
164 |
S1 |
p. S157-S161
|
artikel
|
| 12 |
Arterial thromboembolism risk before a diagnosis of lung, pancreas, or gastric cancer
|
Navi, B.B.
|
|
2018
|
164 |
S1 |
p. S179-S180
|
artikel
|
| 13 |
Arterial thrombosis and cancer
|
Aronson, Doron
|
|
2018
|
164 |
S1 |
p. S23-S28
|
artikel
|
| 14 |
Assessing physician adherence to clinical practice guidelines in the management of cancer-associated venous thromboembolism: a retrospective analysis from a tertiary care centre in Canada
|
Bernstein, M.
|
|
2018
|
164 |
S1 |
p. S204-S205
|
artikel
|
| 15 |
Awareness and understanding of venous thromboembolism in patients with cancer: data on 100 unselected cancer outpatients
|
Nicolau, B.
|
|
2018
|
164 |
S1 |
p. S211-S212
|
artikel
|
| 16 |
Bleeding Rates and Risk Factors among Cancer and Non-Cancer Patients; A Comparison of Several Anticoagulants
|
Angelini, D.E.
|
|
2018
|
164 |
S1 |
p. S185-S186
|
artikel
|
| 17 |
Blocking Tissue Factor signaling in breast cancer inhibits tumor metastasis
|
Ünlü, B.
|
|
2018
|
164 |
S1 |
p. S191-S192
|
artikel
|
| 18 |
Blood rheology and blood clotting in cancer
|
Tikhomirova, I.
|
|
2018
|
164 |
S1 |
p. S228
|
artikel
|
| 19 |
Cancer-associated splanchnic venous thrombosis: clinical findings at presentation
|
García-Villa, A.
|
|
2018
|
164 |
S1 |
p. S211
|
artikel
|
| 20 |
Cancer Associated Thrombosis and anticoagulation; What is the optimal approach?
|
Pandit, N.
|
|
2018
|
164 |
S1 |
p. S207
|
artikel
|
| 21 |
Cancer associated venous thromboembolism: incidence and impact on survival
|
Brunson, A.M.
|
|
2018
|
164 |
S1 |
p. S178-S179
|
artikel
|
| 22 |
Cancer cell-derived microvesicles induce endothelial cell apoptosis mediated through tissue factor, factor VII and PAR2 activation
|
Madkhali, Y.
|
|
2018
|
164 |
S1 |
p. S227
|
artikel
|
| 23 |
Cancer diagnosis as a risk factor of ischemic stroke in atrial fibrillation patients with low stroke risk score
|
Atterman, A.
|
|
2018
|
164 |
S1 |
p. S209
|
artikel
|
| 24 |
Cancer prognosis in patients with venous thromboembolism (VTE) and patients with clinical and laboratory biomarkers predictive of VTE risk
|
Liebman, Howard A.
|
|
2018
|
164 |
S1 |
p. S19-S22
|
artikel
|
| 25 |
Can we use the Khorana risk score to predict venous thromboembolism in patients with cancer? A systematic review and meta-analysis
|
Mulder, F.I.
|
|
2018
|
164 |
S1 |
p. S234
|
artikel
|
| 26 |
Cell surface GRP78 activation by anti-GRP78 autoantibodies confers prostate tumour growth via tissue factor activation
|
Al-Hashimi, A.
|
|
2018
|
164 |
S1 |
p. S226
|
artikel
|
| 27 |
Characterization of thrombosis risk in patients with cancer
|
Cerezuela, P.
|
|
2018
|
164 |
S1 |
p. S236-S237
|
artikel
|
| 28 |
Chronic thromboembolic pulmonary hypertension in cancer patients with pulmonary embolism
|
Catella-Chatron, J.
|
|
2018
|
164 |
S1 |
p. S209-S210
|
artikel
|
| 29 |
Clinical and laboratory characterization of platelet dysfunction caused by ibrutinib treatment in patients with chronic lymphocytic leukemia
|
Alberelli, M.A.
|
|
2018
|
164 |
S1 |
p. S187-S188
|
artikel
|
| 30 |
Clinical case of thrombosis of rare localization in pregnant women with hidden ovarian cancer
|
Vorobev, A.
|
|
2018
|
164 |
S1 |
p. S216
|
artikel
|
| 31 |
Clinical characteristics of disseminated intravascular coagulation in patients with solid and hematological cancers
|
Levi, Marcel
|
|
2018
|
164 |
S1 |
p. S77-S81
|
artikel
|
| 32 |
Clinical dilemmas with cancer-associated splanchnic venous thrombosis in current oncological practice: a case study
|
García-Villa, Adrián
|
|
2018
|
164 |
S1 |
p. S202-S203
|
artikel
|
| 33 |
Clinical impact of bleeding in cancer-associated venous thromboembolism: results from the Hokusai VTE Cancer randomized trial
|
Kraaijpoel, N.
|
|
2018
|
164 |
S1 |
p. S223
|
artikel
|
| 34 |
Clostridium difficile infection is Risk factor of Portal Vein Thrombosis in Hepatocellular Carcinoma Patients
|
Kurniawan, A.
|
|
2018
|
164 |
S1 |
p. S215
|
artikel
|
| 35 |
Coagulation as a pharmacodynamic biomarker in breast cancer: Changes in tumour expression of extrinsic clotting factors in response to breast cancer treatment
|
Castle, J.
|
|
2018
|
164 |
S1 |
p. S181-S182
|
artikel
|
| 36 |
Coagulation factor V is expressed in tumors and predicts favorable outcome in aggressive breast cancer
|
Tinholt, M.
|
|
2018
|
164 |
S1 |
p. S183
|
artikel
|
| 37 |
Current monitoring of fibrinolytic activation in cancer patients treated with chemotherapy
|
Sukhanov, V.
|
|
2018
|
164 |
S1 |
p. S238-S239
|
artikel
|
| 38 |
30-day mortality in cancer patients with atrial fibrillation and bleeding following treatment with warfarin or non-vitamin K oral antagonists
|
Ording, A.G.
|
|
2018
|
164 |
S1 |
p. S220
|
artikel
|
| 39 |
Development and validation of a risk model for prediction of venous thromboembolism in gynaecological cancer patients
|
Norris, L.A.
|
|
2018
|
164 |
S1 |
p. S183-S184
|
artikel
|
| 40 |
Differences in the platelet proteome between patients with cancer at high risk of venous thromboembolism and healthy controls
|
Mauracher, L.M.
|
|
2018
|
164 |
S1 |
p. S181
|
artikel
|
| 41 |
Direct oral anticoagulants do not inhibit growth and metastasis of human triple negative breast cancer in immunodeficient mice
|
Buijs, J.T.
|
|
2018
|
164 |
S1 |
p. S221-S222
|
artikel
|
| 42 |
Dynamic thromboembolism risk modelling in patients with non-small cell lung cancer: a prospective cohort study
|
Alexander, M.
|
|
2018
|
164 |
S1 |
p. S189
|
artikel
|
| 43 |
Editorial Board
|
|
|
2018
|
164 |
S1 |
p. IFC
|
artikel
|
| 44 |
Effectiveness and safety of rivaroxaban versus warfarin for treatment of cancer-associated venous thrombosis
|
Coleman, C.I.
|
|
2018
|
164 |
S1 |
p. S203
|
artikel
|
| 45 |
Effect of ischemic conditioning in patients undergoing cancer surgery: A systematic review
|
Frederiksen, K.
|
|
2018
|
164 |
S1 |
p. S212-S213
|
artikel
|
| 46 |
Effect of the cleavage of human immunoglobulin G by plasmin on the binding and activation of plasminogen
|
Mukhametova, L.I.
|
|
2018
|
164 |
S1 |
p. S227
|
artikel
|
| 47 |
Effects of platelets on cancer progression
|
Plantureux, Léa
|
|
2018
|
164 |
S1 |
p. S40-S47
|
artikel
|
| 48 |
Efficacy and safety of edoxaban in clinically relevant subgroups: results from the Hokusai VTE Cancer randomized trial
|
Mulder, F.I.
|
|
2018
|
164 |
S1 |
p. S194
|
artikel
|
| 49 |
Epidemiologic study of patients with thrombotic events referred to Dastgheib Thrombosis and Hemostasis Research Center in south of Iran (2015-2017)
|
Akbari, A.
|
|
2018
|
164 |
S1 |
p. S218
|
artikel
|
| 50 |
Evidence for the role of procoagulant stromal fibroblasts in the progression of Ductal Carcinoma in Situ
|
Farnie, G.
|
|
2018
|
164 |
S1 |
p. S197-S198
|
artikel
|
| 51 |
Extracellular DNA and histones are dispensable for neutrophil extracellular trap-induced aggregation of human washed platelets
|
Elaskalani, O.
|
|
2018
|
164 |
S1 |
p. S229
|
artikel
|
| 52 |
Extracellular vesicle-associated tissue factor activity is increased in prostate cancer patients with disseminated intravascular coagulation and induced by cellular interactions in vitro
|
Hell, L.
|
|
2018
|
164 |
S1 |
p. S230
|
artikel
|
| 53 |
Extrinsic pathway markers predict survival in Early Breast Cancer
|
Shaker, H.
|
|
2018
|
164 |
S1 |
p. S227-S228
|
artikel
|
| 54 |
Factor Xa inhibitors Apixaban and Rivaroxaban suppress the release of TF-bearing microvesicles from cancer cell lines
|
Featherby, S.
|
|
2018
|
164 |
S1 |
p. S191
|
artikel
|
| 55 |
Fibrinogen, D-Dimers and thrombin generation assays as predictors of the risk of recurrent VTE in patients with gynaecological malignancies
|
Marchocki, Z.
|
|
2018
|
164 |
S1 |
p. S200
|
artikel
|
| 56 |
First External Validation of the New COMPASS-CAT Risk Assessment Model for Ambulatory Patients with Breast, Colorectal, Lung or Ovarian Cancer
|
Gerotziafas, G.T.
|
|
2018
|
164 |
S1 |
p. S232
|
artikel
|
| 57 |
Genes associated with venous thromboembolism in colorectal cancer patients
|
Ünlü, B.
|
|
2018
|
164 |
S1 |
p. S228-S229
|
artikel
|
| 58 |
Hemostatic biomarkers in cancer progression
|
Falanga, Anna
|
|
2018
|
164 |
S1 |
p. S54-S61
|
artikel
|
| 59 |
Hemostatic biomarkers levels for the identification of cancer patients at higher VTE risk enrolled in the HYPERCAN study
|
Verzeroli, C.
|
|
2018
|
164 |
S1 |
p. S198-S199
|
artikel
|
| 60 |
High Incidence of Venous Thromboembolism in Children and Adolescents with Hodgkin's Lymphoma
|
Evstratov, D.
|
|
2018
|
164 |
S1 |
p. S219
|
artikel
|
| 61 |
Hypercoagulable State as innovative tool for risk assessment and early cancer diagnosis: Data from HYPERCAN Prospective Study
|
Gamba, S.
|
|
2018
|
164 |
S1 |
p. S241
|
artikel
|
| 62 |
Incidence of venous thromboembolism in childhood acute leukemia patients - tertiary care centre experience from kingdom of Saudi Arabia
|
AlSaleh, M.
|
|
2018
|
164 |
S1 |
p. S218-S219
|
artikel
|
| 63 |
Incidence of VTE amongst patients undergoing curative resection for colorectal cancer – an underestimated clinical entity
|
Rees, P.A.
|
|
2018
|
164 |
S1 |
p. S233
|
artikel
|
| 64 |
Increased risk of venous thromboembolism (VTE) and shorter survival in neuroendocrine versus castration-resistant prostate cancer
|
Jakubowski, C.
|
|
2018
|
164 |
S1 |
p. S214
|
artikel
|
| 65 |
In patients with cancer, prognostic factors of catheter-related thrombosis (CRT) are different than prognostic factors of VTE. A prospective cohort study in 3032 cancer patients with central venous catheter (ONCOCIP)
|
Decousus, H.
|
|
2018
|
164 |
S1 |
p. S216-S217
|
artikel
|
| 66 |
Integral assessment of the influence of the generalized tumorous process on the hemostasis indices
|
Vasilenko, I.
|
|
2018
|
164 |
S1 |
p. S238
|
artikel
|
| 67 |
Internal and external validation of THROLY (thrombosis lymphoma) score
|
Antic, D.
|
|
2018
|
164 |
S1 |
p. S187
|
artikel
|
| 68 |
Investigate the regulation of PTEN by tissue factor
|
Mohammad, A.
|
|
2018
|
164 |
S1 |
p. S230-S231
|
artikel
|
| 69 |
Joint effects of GP6 rs1613662 and pre-cancer platelet count on the risk of venous thromboembolism in cancer
|
Skille, H.
|
|
2018
|
164 |
S1 |
p. S197
|
artikel
|
| 70 |
Long-term treatment bemiparin in patients with Cancer-Associated Venous Thromboembolism. ELEBAMA study
|
Pascual Elena, P.
|
|
2018
|
164 |
S1 |
p. S204
|
artikel
|
| 71 |
Lower gastrointestinal bleeding and risk of colorectal cancer in users and non-users of low-dose aspirin
|
Schønfeldt Troelsen, F.
|
|
2018
|
164 |
S1 |
p. S239
|
artikel
|
| 72 |
Lymphoma under hospitalized chemotherapy schemes: Specific Thromboembolic Risk Factors and Venous thrombosis incidence
|
Sánchez-Martín, C.
|
|
2018
|
164 |
S1 |
p. S218
|
artikel
|
| 73 |
Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic review
|
Samuleson Bannow, B.
|
|
2018
|
164 |
S1 |
p. S203-S204
|
artikel
|
| 74 |
Management of recurrent venous thromboembolism in patients with cancer: A review
|
Piran, Siavash
|
|
2018
|
164 |
S1 |
p. S172-S177
|
artikel
|
| 75 |
Management of thrombocytopenia in cancer
|
Castaman, Giancarlo
|
|
2018
|
164 |
S1 |
p. S89-S93
|
artikel
|
| 76 |
Marked elevation in plasma factor VIII and VWF levels following neoadjuvant chemotherapy, radiation and major cancer surgery
|
Cunningham, M.
|
|
2018
|
164 |
S1 |
p. S195-S196
|
artikel
|
| 77 |
Mechanisms and management of coagulopathy in acute promyelocytic leukemia
|
David, Sachin
|
|
2018
|
164 |
S1 |
p. S82-S88
|
artikel
|
| 78 |
Mechanisms coupling thrombin to metastasis and tumorigenesis
|
Remiker, Allison S.
|
|
2018
|
164 |
S1 |
p. S29-S33
|
artikel
|
| 79 |
Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer
|
Lyman, Gary H.
|
|
2018
|
164 |
S1 |
p. S112-S118
|
artikel
|
| 80 |
Mouse models of cancer-associated thrombosis
|
Hisada, Yohei
|
|
2018
|
164 |
S1 |
p. S48-S53
|
artikel
|
| 81 |
Mural thrombus of ascending aorta successfully managed with anticoagulation in a patient with metastasic cancer
|
Rodríguez, A.
|
|
2018
|
164 |
S1 |
p. S222-S223
|
artikel
|
| 82 |
Neutrophil-to-Lymphocyte Ratio and the Risk of Venous Thromboembolism and Mortality in Patients with Cancer
|
Grilz, E.
|
|
2018
|
164 |
S1 |
p. S232-S233
|
artikel
|
| 83 |
New generation flow-cytometry to measure circulating microvesiscles in cancer
|
Campello, E.
|
|
2018
|
164 |
S1 |
p. S242-S243
|
artikel
|
| 84 |
Non-bacterial endocarditis as an initial presentation of a Trousseau's Syndrome? A complex diagnostic challenge. Case report
|
Vilaseca, A.B.
|
|
2018
|
164 |
S1 |
p. S208
|
artikel
|
| 85 |
Novel strategies of coagulation inhibition for reducing tumor growth and angiogenesis
|
Nadir, Yona
|
|
2018
|
164 |
S1 |
p. S153-S156
|
artikel
|
| 86 |
Overview of VTE treatment in cancer according to clinical guidelines
|
Lee, Agnes Y.Y.
|
|
2018
|
164 |
S1 |
p. S162-S167
|
artikel
|
| 87 |
Patient and carer experience of oral and injected anticoagulation for cancer-associated thrombosis: select-d trial qualitative sub-study
|
Hutchinson, A.
|
|
2018
|
164 |
S1 |
p. S206-S207
|
artikel
|
| 88 |
Patient Perspectives of Thromboprophylaxis in Multiple Myeloma: Results from the Thromboprophylaxis in Multiple Myeloma (TiMM) study
|
Sayar, Z.
|
|
2018
|
164 |
S1 |
p. S189-S190
|
artikel
|
| 89 |
Patients experience and compliance with extended LMWH prophylaxis post-surgery for gynaecological cancer
|
Marchocki, Z.
|
|
2018
|
164 |
S1 |
p. S235
|
artikel
|
| 90 |
Patient, tumour and operative factors influencing perioperative hypercoagulability in colorectal cancer
|
Rees, P.A.
|
|
2018
|
164 |
S1 |
p. S213
|
artikel
|
| 91 |
Performance of the RIETE score in an unselected VTE cohort
|
Rosell, A.
|
|
2018
|
164 |
S1 |
p. S233-S234
|
artikel
|
| 92 |
Platelets, NETs and cancer
|
Cedervall, Jessica
|
|
2018
|
164 |
S1 |
p. S148-S152
|
artikel
|
| 93 |
Predictive factors of fatal bleeding in acute promyelocytic leukemia
|
Mantha, Simon
|
|
2018
|
164 |
S1 |
p. S98-S102
|
artikel
|
| 94 |
Predictors of cancer-associated thrombosis in gastro-intestinal cancer: preliminary results
|
Campello, E.
|
|
2018
|
164 |
S1 |
p. S199-S200
|
artikel
|
| 95 |
Preface
|
Falanga, Anna
|
|
2018
|
164 |
S1 |
p. S1-S2
|
artikel
|
| 96 |
Pre-operative systemic coagulation factors as biomarkers in colorectal cancer
|
Rees, P.A.
|
|
2018
|
164 |
S1 |
p. S239-S240
|
artikel
|
| 97 |
Prophylaxis and treatment of venous thromboembolism: data on a survey amongst members of the Spanish Medical Oncology Society
|
Font, C.
|
|
2018
|
164 |
S1 |
p. S201
|
artikel
|
| 98 |
Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Newly diagnosed chemotherapy Naïve Patients with Multiple Myeloma at Risk for Cancer-associated Thrombosis. The Observational ROADMAP-CAT-MM Study
|
Fotiou, D.
|
|
2018
|
164 |
S1 |
p. S235
|
artikel
|
| 99 |
Prothrombotic dominance in patients with chronic cerebrovascular diseases comorbided with myeloproliferative neoplasms
|
Roitman, E.
|
|
2018
|
164 |
S1 |
p. S198
|
artikel
|
| 100 |
Prothrombotic genotypes and risk of venous thromboembolism in cancer
|
Gran, Olga V.
|
|
2018
|
164 |
S1 |
p. S12-S18
|
artikel
|
| 101 |
Rare localization thrombosis as manifestation of occult cancer: clinical case
|
Vorobev, A.
|
|
2018
|
164 |
S1 |
p. S208-S209
|
artikel
|
| 102 |
Recurrence of venous thromboembolism among non small cell lung cancer patients treated with EGFR inhibitors
|
Varchetta, V.
|
|
2018
|
164 |
S1 |
p. S201
|
artikel
|
| 103 |
Relationship between ultrasonographic findings and post-thrombotic syndrome in cancer associated thrombosis
|
Romera-Villegas, A.
|
|
2018
|
164 |
S1 |
p. S240-S241
|
artikel
|
| 104 |
Retinal vein thrombosis and risk of cancer: A population-based cohort study
|
Hansen, A.T.
|
|
2018
|
164 |
S1 |
p. S209
|
artikel
|
| 105 |
Retrospective cohort study of venous thromboembolism rates in ambulatory cancer patients, association with Khorana score and other risk factors
|
Austin, K.
|
|
2018
|
164 |
S1 |
p. S214-S215
|
artikel
|
| 106 |
Revisiting occult cancer screening in patients with unprovoked venous thromboembolism
|
Robin, Philippe
|
|
2018
|
164 |
S1 |
p. S7-S11
|
artikel
|
| 107 |
Risk and Prognosis of Cancer after Lower Limb Arterial Thrombosis
|
Sundbøll, J.
|
|
2018
|
164 |
S1 |
p. S179
|
artikel
|
| 108 |
Risk and prognosis of cancer after upper-extremity deep venous thrombosis: A population-based cohort study
|
Adelborg, K.
|
|
2018
|
164 |
S1 |
p. S215-S216
|
artikel
|
| 109 |
Risk of recurrence and bleeding with Rivaroxaban among patients with venous thromboembolism and active cancer
|
Søgaard, M.
|
|
2018
|
164 |
S1 |
p. S240
|
artikel
|
| 110 |
Risk prediction of cancer-associated thrombosis: Appraising the first decade and developing the future
|
Khorana, Alok A.
|
|
2018
|
164 |
S1 |
p. S70-S76
|
artikel
|
| 111 |
Risk scores for occult cancer in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study
|
Kraaijpoel, N.
|
|
2018
|
164 |
S1 |
p. S224
|
artikel
|
| 112 |
Role of ADAMTS5 in non-alcoholic steatohepatitis
|
Lijnen, H.R.
|
|
2018
|
164 |
S1 |
p. S242
|
artikel
|
| 113 |
Single cell coagulomes as constituents of the oncogene-driven coagulant phenotype in brain tumours
|
Tawil, Nadim
|
|
2018
|
164 |
S1 |
p. S136-S142
|
artikel
|
| 114 |
Small cell lung cancer patients and venous thromboembolism: The need of anticoagulation treatment
|
Dimakakos, E.
|
|
2018
|
164 |
S1 |
p. S220
|
artikel
|
| 115 |
Study of the endothelial dysfunction in patients with gastro-intestinal cancer: preliminary results
|
Campello, E.
|
|
2018
|
164 |
S1 |
p. S226
|
artikel
|
| 116 |
Superior vena cava syndrome in lung cancer patients: How to prevent its venous thromboembolism complications
|
Dimakakos, E.
|
|
2018
|
164 |
S1 |
p. S237
|
artikel
|
| 117 |
Systematic review and meta-analysis of real-world studies evaluating rivaroxaban for cancer-associated venous thrombosis
|
Martinez, B.K.
|
|
2018
|
164 |
S1 |
p. S205
|
artikel
|
| 118 |
The action of Erythropoietin on venous thromboembolic events in lung cancer patients
|
Dimakakos, E.
|
|
2018
|
164 |
S1 |
p. S242
|
artikel
|
| 119 |
The combination of podoplanin expression levels and IDH1 mutation status predicts VTE risk in patients with brain tumors
|
Nazari, P.M.S.
|
|
2018
|
164 |
S1 |
p. S195
|
artikel
|
| 120 |
The diagnostic potential of ‘high normal’ platelet counts for identifying cancer in primary care
|
Bailey, S.E.R.
|
|
2018
|
164 |
S1 |
p. S199
|
artikel
|
| 121 |
The effects of exogenous coagulation factors, and their inhibitors, on in vitro proliferation and migration in colorectal cancer
|
Rees, P.A.
|
|
2018
|
164 |
S1 |
p. S222
|
artikel
|
| 122 |
The impact of FGG rs2066865 and pre-cancer fibrinogen concentration on cancer-related venous thromboembolism (VTE)
|
Paulsen, B.
|
|
2018
|
164 |
S1 |
p. S197
|
artikel
|
| 123 |
The intersection of protein disulfide isomerase and cancer associated thrombosis
|
Stopa, Jack D.
|
|
2018
|
164 |
S1 |
p. S130-S135
|
artikel
|
| 124 |
The role of podoplanin in cancer-associated thrombosis
|
Mir Seyed Nazari, Pegah
|
|
2018
|
164 |
S1 |
p. S34-S39
|
artikel
|
| 125 |
Threatened abortion and risk of cancer
|
Dudukina, E.
|
|
2018
|
164 |
S1 |
p. S210
|
artikel
|
| 126 |
Thrombin generation predicts for early recurrence in breast cancer patients undergoing post-surgical adjuvant therapy: results from the HYPERCAN study.
|
Giaccherini, C.
|
|
2018
|
164 |
S1 |
p. S196
|
artikel
|
| 127 |
Thrombosis in pediatric patients with leukemia
|
Levy-Mendelovich, Sarina
|
|
2018
|
164 |
S1 |
p. S94-S97
|
artikel
|
| 128 |
Thrombotic microangiopathy in cancer
|
Weitz, Ilene Ceil
|
|
2018
|
164 |
S1 |
p. S103-S105
|
artikel
|
| 129 |
Tissue factor as a mediator of coagulation and signaling in cancer and chronic inflammation
|
Graf, Claudine
|
|
2018
|
164 |
S1 |
p. S143-S147
|
artikel
|
| 130 |
Treatment and long-term clinical outcomes of incidental pulmonary embolism in cancer patients: an international prospective cohort study
|
Kraaijpoel, N.
|
|
2018
|
164 |
S1 |
p. S193-S194
|
artikel
|
| 131 |
Treatment of venous thromboembolism in patients with cancer: What news from clinical trials?
|
Verso, Melina
|
|
2018
|
164 |
S1 |
p. S168-S171
|
artikel
|
| 132 |
Treatment Outcomes of Cancer Associated Venous Thrombosis; The Cleveland Clinic Experience
|
Angelini, D.E.
|
|
2018
|
164 |
S1 |
p. S205-S206
|
artikel
|
| 133 |
Tumor cell-induced endothelial pro-thrombotic phenotype is inhibited by heparins
|
Vignoli, A.
|
|
2018
|
164 |
S1 |
p. S223-S224
|
artikel
|
| 134 |
Updated clinical models for VTE prediction in hospitalized medical patients
|
Gerotziafas, Grigoris T.
|
|
2018
|
164 |
S1 |
p. S62-S69
|
artikel
|
| 135 |
Update for: Thrombin Inhibition Preoperatively (TIP) in Early Breast Cancer, the first clinical trial of DOACs as an anti-cancer agent
|
Castle, J.
|
|
2018
|
164 |
S1 |
p. S224-S225
|
artikel
|
| 136 |
Validation of the Khorana score in lung cancer patients: a new predictor of early mortality?
|
Vathiotis, I.
|
|
2018
|
164 |
S1 |
p. S233
|
artikel
|
| 137 |
Venous Thromboembolic Complications in Patients with Cancer Corpus Uteri
|
Strøm Kahr, H.
|
|
2018
|
164 |
S1 |
p. S217
|
artikel
|
| 138 |
Venous Thromboembolic Complications in Patients with Ovarian Cancer compared to Patients with Benign Ovarian Tumours
|
Strøm Kahr, H.
|
|
2018
|
164 |
S1 |
p. S215
|
artikel
|
| 139 |
Venous thromboembolism risk assessment of hospitalised cancer patients in a tertiary referral centre
|
Murphy, D.
|
|
2018
|
164 |
S1 |
p. S235-S236
|
artikel
|
| 140 |
Venous thrombosis and lymphoma: a monocentric reports of 13 cases
|
Tazi-Mezalek, Z.
|
|
2018
|
164 |
S1 |
p. S210-S211
|
artikel
|
| 141 |
What is the real incidence of VTE recurrence in cancer patients. Impact of statistical methodologies. ELEBAMA study
|
Elena, P.P.
|
|
2018
|
164 |
S1 |
p. S241
|
artikel
|
Tijdschrift beschrijving